AstraZeneca Plc (AZN) on Tuesday said it will acquire biotech company Fusion Pharmaceuticals Inc. (FUSN) for up to $2.4 billion, expanding its pipeline of treatment for advanced prostate cancer. More @Wikipedia
Get the latest news about Fusion Pharmaceuticals from the top news sites, aggregators and blogs. Also included are videos, photos, and websites related to Fusion Pharmaceuticals.
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.